跳至主要内容
临床试验/IRCT20190425043368N1
IRCT20190425043368N1招募中3 期

The evaluation of clinical and laboratory efficacy of four-hour infusion vs. half-hour infusion of Ampicillin-Sulbactam in empiric and definite treatment of patients with sepsis and severe sepsis in the intensive care unit of Namazee and shahid Rajaee hospital in Shiraz.

Shiraz University of Medical Sciences0 个研究点目标入组 136 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
招募中
入组人数
136

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 no limit(—)
性别
All

入选标准

  • More than 18 years old
  • Diagnosis of sepsis and severe sepsis based on qSOFA criteria
  • Taking Ampicillin- Sulbactam at least for three days

排除标准

  • Sensitivity to Ampicillin- Sulbactam
  • Receiving Ampicillin- Sulbactam more than 24 hours during 1 week before being admitted to the intensive care unit
  • Patients with GFR<10 ml/min or hemodialysis
  • Patients with Pseudomonas, penicillin-resistant staph aureus (MRSA), or stenotrophomonas

研究者

相似试验

The comparison between short and long infusion of... | 临床试验